{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:43Z","timestamp":1790015503156,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.clim.2008.05.001","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T05:10:33Z","timestamp":1214457033000},"page":"340-348","source":"Crossref","is-referenced-by-count":17,"title":["Systemic administration of an Fc\u03b3\u2013Fc\u03b5-fusion protein in house dust mite sensitive nonhuman primates"],"prefix":"10.1016","volume":"128","author":[{"given":"Michael R.","family":"Van Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Mertsching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Negrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Howard W.","family":"Stallings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn R.","family":"Kehry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2008.05.001_bib1","doi-asserted-by":"crossref","first-page":"S526","DOI":"10.1016\/j.jaci.2005.01.028","article-title":"Diversity of asthma: evolving concepts of pathophysiology and lessons from genetics","volume":"115","author":"Lilly","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1146\/annurev.immunol.17.1.931","article-title":"The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology","volume":"17","author":"Kinet","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.170.2.775","article-title":"Long term maintenance of IgE-mediated memory in mast cells in the absence of detectable serum IgE","volume":"170","author":"Kubo","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2005.11.008","article-title":"Fc receptors as determinants of allergic reactions","volume":"27","author":"Kraft","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0952-7915(02)00400-4","article-title":"Inhibitory receptors and allergy","volume":"14","author":"Katz","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"1","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2008.05.001_bib8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(01)56900-7","article-title":"Vaccination against hay fever: report of results during the first three years","volume":"1","author":"Freeman","year":"1914","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2008.05.001_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm0502-518","article-title":"A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation","volume":"8","author":"Zhu","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2008.05.001_bib10","doi-asserted-by":"crossref","first-page":"32818","DOI":"10.1074\/jbc.M304590200","article-title":"Inhibition of interleukin-4-induced class switch recombination by a human immunoglobulin Fc gamma-Fc epsilon chimeric protein","volume":"278","author":"Yamada","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2008.05.001_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2004.03.058","article-title":"Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein","volume":"114","author":"Zhang","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2008.05.001_bib12","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1152\/japplphysiol.01128.2003","article-title":"Dust mite-induced asthma in cynomolgus monkeys","volume":"96","author":"Van Scott","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.clim.2008.05.001_bib13","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1152\/japplphysiol.00537.2005","article-title":"Separation of bronchoconstriction from increased ventilatory drive in a nonhuman primate model of chronic allergic asthma","volume":"99","author":"Van Scott","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.clim.2008.05.001_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00130832-200412000-00015","article-title":"Genetically engineered negative signaling molecules in the immunomodulation of allergic diseases","volume":"4","author":"Saxon","year":"2004","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2008.05.001_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2007.08.051","article-title":"A mouse Fcgamma\u2013Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases","volume":"121","author":"Mertsching","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2008.05.001_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nbt1303","article-title":"A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs","volume":"25","author":"Shankar","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.clim.2008.05.001_bib17","first-page":"10","article-title":"Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans","volume":"6","author":"Bugelski","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"9","key":"10.1016\/j.clim.2008.05.001_bib18","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"Suppl 6","key":"10.1016\/j.clim.2008.05.001_bib19","doi-asserted-by":"crossref","first-page":"vi3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins","volume":"20","author":"Schellekens","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2008.05.001_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd818","article-title":"Bioequivalence and the immunogenicity of biopharmaceuticals","volume":"1","author":"Schellekens","year":"2002","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661608006529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661608006529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T10:55:28Z","timestamp":1545908128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661608006529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1521661608006529"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2008.05.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}